Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide.Glucagon-like peptide-1 receptor agonists gained approval as drugs to treat diabetes and obesity starting in the 2000s.
GLP-1 RA treatment improves the redox state and mitochondrial respiration, and reduces leukocyte-endothelial interactions, inflammation and CIMT in T2D patients, thereby potentially diminishing the risk of atherosclerosis and CVDs.
Glucagon-like peptide-1 receptor (GLP-1R) agonists (GLP-1RAs) ameliorate mitochondrial health by increasing mitochondrial turnover in metabolically relevant tissues. Mitochondrial adaptation to ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...
paradigm shifts in glucagon-like peptide-1 receptor (GLP-1R) signaling from diffuse events to spatiotemporally organized signalosomes offer insightful mechanisms into these conditions. The localization of internalized GLP-1Rs at the Mitochondria-ER interface supports a contactomics framework for understanding bioenergetic restoration.
Glucagon-like peptide-1 receptor agonists (GLP-1-RA) are used to treat diabetes mellitus and obesity and have reduced cardiovascular risk in clinical trials. It has been hypothesized that GLP-1-RA exert cardioprotective effects beyond weight loss or glycemic control, however, the underlying mechanisms are unclear. Animal studies suggest that GLP-1-RA enhance myocardial mitochondrial function ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are emerging as potential neuroprotective drugs in neurodegenerative diseases. These drugs were initially developed to manage type 2 diabetes (T2D) and obesity. In addition to GLP-1RAs having an impact on metabolic pathways, growing evidences suggests that GLP-1RAs also positively regulate mitochondrial homeostasis in several neuronal cell ...
Moving forward, it's essential to keep these visual contexts in mind when discussing Glp-1 Receptor Agonist Mitochondrial Function.
Changes in mitochondrial function can lead to dysfunction and cell death in aging and age-related disorders. Recent research suggests that mitochondrial dysfunction is closely linked to neurodegenerative diseases. Glucagon-like peptide-1 receptor (GLP-1R) agonist has...
GLP-1 receptor agonists have emerged as biologically plausible modulators of reward circuitry and addictive behavior. Preclinical data are robust and consistent across substances, while human evidence provides encouraging but non-causal signals.
